Delivery Order SPE2DB20D3103-SPE2DB25FQ1N9
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency awarded a delivery order valued at $7,354.05 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, an intravenous antibiotic formulation used for bacterial infections in military and federal healthcare settings. The contract, executed on September 3, 2025, with an ultimate completion date of September 4, 2025, employs firm fixed pricing under a non-competitive, non-set-aside delivery order arrangement. Performance will occur at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,854.60 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for ultimate completion by September 5, 2025. The contract represents a continuation of AmerisourceBergen's substantial role as a critical federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $91,205.68 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded contract (no set-aside designation) represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $125,954.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery contract vehicle, carries an ultimate completion date of August 8, 2025. The award was made through competitive procurement with no set-aside designation, reflecting the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,910.72 delivery order contract by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,570.72 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under a larger indefinite delivery contract (IDC) and will be performed at the vendor's corporate office location in Conshohocken, PA, with an ultimate completion date of September...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,812.96 by the Defense Logistics Agency's Medical Supply Chain on August 9, 2025. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 11, 2025, with performance taking place at the contractor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,259.07 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1N9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Cefepime-Dextrose 2 GM/50 MLS. This competitively awarded, firm fixed-price delivery order is valued at $12,695.91 and carries an ultimate completion date of September 5, 2025. The product will be delivered to the Conshohocken, PA location. As a child contract under a larger vehicle, this delivery order represents a single pharmaceutical transaction within AmerisourceBergen's extensive federal medical supply portfolio. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a vast array of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. Cefepime-Dextrose, an antibiotic solution commonly used in critical care and hospital settings, reflects the types of essential medications distributed through this strategic partnership to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 9/4/25 |